ENOVIS CORP DRNENOVIS CORP DRNENOVIS CORP DRN

ENOVIS CORP DRN

No trades
See on Supercharts
Market capitalization
‪13.50 B‬BRL
−8.959BRL
‪−237.13 M‬BRL
‪8.30 B‬BRL
‪54.15 M‬
Beta (1Y)
0.32

About Enovis Corporation

CEO
Matthew L. Trerotola
Website
Headquarters
Wilmington
Employees (FY)
‪6.55 K‬
Founded
1995
ISIN
BRE2NOBDR001
FIGI
BBG017K4QVX9
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.